Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;44(2):197-203.
doi: 10.1007/s15010-015-0842-2. Epub 2015 Sep 9.

Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study

Marilia Rita Pinzone  1 , Daniela Castronuovo  1 , Adriana Di Gregorio  1 , Benedetto Maurizio Celesia  1 , Maria Gussio  1 , Marco Borderi  2 , Paolo Maggi  3 , Carmen Rita Santoro  3 , Giordano Madeddu  4 , Bruno Cacopardo  1 , Giuseppe Nunnari  5
Affiliations

Heel quantitative ultrasound in HIV-infected patients: a cross-sectional study

Marilia Rita Pinzone et al. Infection. 2016 Apr.

Abstract

Purpose: HIV infection has been associated with increased risk of osteoporosis and fragility fractures. Dual-energy X-ray absorptiometry (DXA) is the reference standard to assess bone mineral density (BMD); however, it is not easily accessible in several settings. Heel Quantitative ultrasound (QUS) is a radiation-free, easy-to-perform technique, which may help reducing the need for DXA.

Methods: In this cross-sectional study, we used heel QUS (Hologic Sahara(®)) to assess bone status in a cohort of HIV-infected patients. A QUS stiffness index (QUI) threshold >83 was used to identify patients with a low likelihood of osteoporosis. Moreover, we compared QUS results with those of 36 sex- and age-matched HIV-negative controls.

Results: 244 HIV-positive patients were enrolled. Median heel QUI value was 83 (73-96) vs. 93 (IQR 84-104) in the control group (p = 0.04). 110 patients (45 %) had a QUI value ≤83. Risk factors for low QUI values were age (OR 1.04 per year, 95 % CI 1.01-1.07, p = 0.004), current use of protease inhibitors (OR 1.85, CI 1.03-3.35, p = 0.039), current use of tenofovir (OR 2.28, CI 1.22-4.27, p = 0.009) and the number of risk factors for secondary osteoporosis (OR 1.46, CI 1.09-1.95, p = 0.01). Of note, QUI values were significantly correlated with FRAX score (r = -0.22, p = 0.004). According to EACS guidelines, 45 % of patients had risk factors for osteoporosis which make them eligible for DXA. By using QUS, we may avoid DXA in around half of them.

Conclusions: As HIV-positive patients are living longer, the prevalence of osteoporosis is expected to increase over time. Appropriate screening, prevention and treatment are crucial to preserve bone health in this population. The use of screening techniques, such as heel QUS, may help reducing the need for DXA. Further studies are needed to define the diagnostic accuracy of this promising technique in the setting of HIV.

Keywords: BMD; DXA; HIV; Heel; Osteoporosis; QUS.

PubMed Disclaimer

References

    1. Osteoporos Int. 2015 May;26(5):1459-75 - PubMed
    1. Eur Rev Med Pharmacol Sci. 2013 Sep;17(18):2413-9 - PubMed
    1. HIV Med. 2014 Jul;15(6):373-80 - PubMed
    1. Eur Rev Med Pharmacol Sci. 2013 Jul;17 (14 ):1938-50 - PubMed
    1. Osteoporos Int. 2013 Mar;24(3):1015-22 - PubMed

Publication types

LinkOut - more resources